bpc-157 peptide clinical trials Planned by Johns Hopkins Physician | Christopher L. Robinson, MD PhD posted on the topic bpc-157 human clinical trials evidence

Peptides are typically administered through subcutaneous injections, which can be done conveniently at home after proper instruction, or through other methods like nasal sprays, creams, or tablets, depending on the specific peptide and protocol

In the Diabetes Prevention Program Outcomes Study, low B12 occurred more often in the metformin group than placebo at 5 years (4.3% vs 2.3%), and combined low plus borderline-low B12 was far more common in metformin users at both 5 years (19.1% vs 9.5%) and 13 years (20.3% vs 15.6%)

Some discomfort and temporary redness may appear for a short time

11 If necessary this treatment is repeated within several hours, making the total dose 10 grams